TFX

Teleflex Incorporated
$134.61
-0.61 (-0.45%)
Mkt Cap 5.96B
Volume 305,820
52W Range 100.18-139.67
Sector Healthcare
Beta 0.82
EPS (TTM) -22.80
P/E Ratio -6.01
Revenue (TTM) 2.81B
Rev Growth (5Y) -4.7%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$121.39
Overvalued weak signal
10.9% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
D
Stable Earnings Power
36.4 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 1.99B 3.05B 2.97B 2.79B 2.81B 2.54B 2.60B 2.45B 2.15B 1.87B 1.81B 1.84B
Net Income (905.64M) 69.67M 356.33M 363.14M 485.37M 335.32M 461.47M 200.80M 152.53M 237.38M 244.86M 187.68M
EPS -20.30 1.49 7.58 7.74 10.38 7.21 9.99 4.39 3.39 5.48 5.89 4.54
Free Cash Flow 245.44M 509.31M 419.20M 262.95M 579.80M 345.71M 336.83M 356.58M 348.98M 355.35M 239.36M 218.99M
FCF / Share 5.50 10.87 8.92 5.61 12.40 7.44 7.29 7.80 7.75 8.20 5.76 5.29
Operating CF 340.68M 635.74M 510.64M 342.14M 651.42M 436.41M 439.52M 437.38M 419.88M 408.48M 300.81M 286.56M
Total Assets 6.95B 7.10B 7.53B 6.93B 6.87B 7.15B 6.31B 6.28B 6.18B 3.89B 3.88B 3.98B
Total Debt 2.73B 1.76B 1.93B 1.83B 1.97B 2.56B 2.01B 2.16B 2.25B 1.03B 1.07B 1.07B
Cash & Equiv 393.26M 290.19M 222.85M 292.03M 445.08M 375.88M 301.08M 357.16M 333.56M 543.79M 338.37M 303.24M
Book Value 3.12B 4.28B 4.44B 4.02B 3.75B 3.34B 2.98B 2.54B 2.43B 2.14B 2.01B 1.91B
Return on Equity -0.29 0.02 0.08 0.09 0.13 0.10 0.15 0.08 0.06 0.11 0.12 0.10
TFX News
Teleflex Publishes 2025 Global Impact Report
Jul 07, 2026 02:30 AM · businesswire.com
Do Options Traders Know Something About Teleflex Stock We Don't?
Jun 24, 2026 08:35 AM · zacks.com
Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold
Jun 23, 2026 02:30 AM · businesswire.com
Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)
Jun 09, 2026 02:30 AM · businesswire.com
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering
Jun 01, 2026 01:40 PM · businesswire.com
TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank
Jun 01, 2026 07:15 AM · zacks.com
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032
Jun 01, 2026 03:45 AM · businesswire.com
Teleflex Divestitures: What Investors Should Watch in 2026
May 29, 2026 06:50 AM · zacks.com
Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer
May 21, 2026 02:30 AM · businesswire.com
Teleflex Announces Quarterly Dividend
May 15, 2026 12:30 PM · businesswire.com